PharmaCyte Biotech CEO Interviewed by Small Cap Nation
June 28, 2016 12:31 ET
|
PharmaCyte Biotech, Inc.
SILVER SPRING, Md., June 28, 2016 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and...
PharmaCyte Biotech Releases Medical and Scientific Discussion from 2016 ASCO Annual Meeting
June 23, 2016 09:20 ET
|
PharmaCyte Biotech, Inc.
SILVER SPRING, Md., June 23, 2016 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and diabetes...
PharmaCyte Biotech CEO Interviewed Live During Marcum MicroCap Conference
June 20, 2016 09:00 ET
|
PharmaCyte Biotech, Inc.
SILVER SPRING, Md., June 20, 2016 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and diabetes...
PharmaCyte Biotech to Present Cancer and Diabetes Therapies at 2016 BIO International Convention
June 07, 2016 09:20 ET
|
PharmaCyte Biotech, Inc.
SILVER SPRING, Md., June 07, 2016 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and...
PharmaCyte Biotech Officers to Attend Annual Meeting of the American Society of Clinical Oncology
June 03, 2016 09:20 ET
|
PharmaCyte Biotech, Inc.
SILVER SPRING, Md., June 03, 2016 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and...
PharmaCyte Biotech’s CEO Featured Speaker at Marcum MicroCap Conference
May 31, 2016 09:20 ET
|
PharmaCyte Biotech, Inc.
SILVER SPRING, Md., May 31, 2016 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and diabetes...
PharmaCyte Biotech to Present Clinical Trial at Marcum MicroCap, ASCO and BIO International Conferences
May 26, 2016 09:20 ET
|
PharmaCyte Biotech, Inc.
SILVER SPRING, Md., May 26, 2016 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and...
PharmaCyte Biotech to Engage Principal Investigator for Clinical Trial in Pancreatic Cancer
May 24, 2016 09:00 ET
|
PharmaCyte Biotech, Inc.
SILVER SPRING, Md., May 24, 2016 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and diabetes...
PharmaCyte Biotech Receives ‘Notice of Allowance’ for Patent Protection of the Melligen Cells to Treat Diabetes
May 12, 2016 09:33 ET
|
PharmaCyte Biotech, Inc.
SILVER SPRING, Md., May 12, 2016 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and diabetes...
PharmaCyte Biotech Appoints Former Johnson & Johnson Executive as Senior Business Development Advisor
May 03, 2016 09:25 ET
|
PharmaCyte Biotech, Inc.
SILVER SPRING, Md., May 03, 2016 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and diabetes...